For example, a study involving 854 patients with pancreatic ductal adenocarcinoma showed that 12 patients (1.4 %) had BRCA2 and 3 patients (0.35 %) had BRCA1 deleterious germline mutations [13]. Here, BRCA2 is linked to pancreatic ductal adenocarcinoma.